Neurology/psychiatric Chengdu Mfs Pharma synthesizes new compounds for pain April 23, 2026 Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for use as an anesthetic.Read More
Neurology/psychiatric Chengdu Mfs Pharma patents new compounds for pain, anesthesia and epilepsy Feb. 24, 2025 Chengdu Mfs Pharma Co. Ltd. has disclosed compounds reported to be useful for pain, anesthesia, sleep disorders and status epilepticus epilepsy.Read More
Neurology/psychiatric Chengdu Mfs Pharma identifies analgesic agents July 24, 2024 Chengdu Mfs Pharma Co. Ltd. has disclosed substituted phenol derivatives potentially useful as analgesics, sedatives, hypnotics and anesthetics.Read More